UB Paderborn / Katalog / Suche / in CDI

The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets

Pharmacopsychiatry, 2009-07, Vol.42 (4), p.158

2009

Volltextzugriff (PDF)

Clinical pharmacokinetics of topotecan

Clinical pharmacokinetics, 1996-08, Vol.31 (2), p.85-102

1996

Volltextzugriff (PDF)

Oral topotecan: bioavailability and effect of food co-administration

British Journal of Cancer, 1999-07, Vol.80 (9), p.1380-1386

1999

Volltextzugriff (PDF)

Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.1067

1999

Volltextzugriff (PDF)

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide

British journal of cancer, 1997, Vol.76 (11), p.1500-1508

1997

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks

British journal of cancer, 2004-06, Vol.90 (12), p.2268-2277

2004

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of the Combination of Paclitaxel, Cisplatin, and Topotecan Administered Intravenously Every 21 Days as First-Line Therapy in Patients With Advanced Ovarian Cancer

Journal of clinical oncology, 1999-03, Vol.17 (3), p.747-755

1999

Volltextzugriff (PDF)

Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam

The Journal of pharmacology and experimental therapeutics, 1998-01, Vol.284 (1), p.202

1998

Volltextzugriff (PDF)

Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan

Cancer chemotherapy and pharmacology, 1997-02, Vol.39 (6), p.498-504

1997

Volltextzugriff (PDF)

Distribution of ifosfamide and metabolites between plasma and erythrocytes

Biopharmaceutics & drug disposition, 2001-04, Vol.22 (3), p.99-108

2001

Volltextzugriff (PDF)

High-performance liquid chromatographic analysis of the investigational anticancer drug 9-aminocamptothecin, as the lactone form and as the total of the lactone and the hydroxycarboxylate forms, in micro-volumes of human plasma

Journal of pharmaceutical and biomedical analysis, 1998-09, Vol.17 (8), p.1257-1265

1998

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of a Daily Times 5 Short Intravenous Infusion Schedule of 9-Aminocamptothecin in a Colloidal Dispersion Formulation in Patients With Advanced Solid Tumors

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1906-1914

1999

Volltextzugriff (PDF)

Sensitive Determination of the Carboxylate and Lactone Forms of the Novel Antitumor Drug Irinotecan and Its Active Metabolite in Plasma by HPLC

Journal of liquid chromatography & related technologies, 1998-06, Vol.21 (10), p.1541-1558

1998

Volltextzugriff (PDF)

Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer

Anti-cancer drugs, 1998-06, Vol.9 (5), p.411-418

1998

Volltextzugriff (PDF)

Phase I and pharmacokInetic (PK) study of Irinotecan (CPT11) with a prolonged (14D) infusion schedule

European journal of cancer (1990), 1997-09, Vol.33, p.S253-S253

1997

Volltextzugriff (PDF)

Oral topotecan: bioavailablity and effect of food co-administration

British journal of cancer, 1999-07, Vol.80 (9), p.1380-1386

1999

Volltextzugriff (PDF)

Oral Bioavailability of Low Dose (20mg) ‘Home-Made’ Etoposide Capsules

Clinical drug investigation, 1996-12, Vol.12 (6), p.298-307

1996

Volltextzugriff (PDF)

Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors

Pharmacy world and science, 1998-08, Vol.20 (4), p.161-172

1998

Volltextzugriff (PDF)

Deficits in facial emotion recognition indicate behavioral changes and impaired self-awareness after moderate to severe traumatic brain injury

PloS one, 2013-06, Vol.8 (6), p.e65581-e65581

2013

Volltextzugriff (PDF)

Ant-induced soil modification and its effect on plant below-ground biomass

Pedobiologia, 2005-01, Vol.49 (2), p.127-137

2005

Volltextzugriff (PDF)

Modal transmission-line modeling of propagation of plane radiowaves through multilayer periodic building structures

IEEE transactions on antennas and propagation, 2003-09, Vol.51 (9), p.2244-2251

2003

Volltextzugriff (PDF)

Variation in plant performance in a grassland: Species-specific and neighbouring root mass effects

Journal of vegetation science, 2007-02, Vol.18 (1), p.55-62

2007

Volltextzugriff (PDF)

Vegetation changes following sheep grazing in abandoned mountain meadows

Applied vegetation science, 2001-06, Vol.4 (1), p.97-102

2001

Volltextzugriff (PDF)

Year-to-Year Variation in Plant Competition in a Mountain Grassland

The Journal of ecology, 2003-02, Vol.91 (1), p.103-113

2003

Volltextzugriff (PDF)

Interspecific competition changes reproductive output but does not increase reproductive costs in a grassland perennial

Basic and applied ecology, 2009-09, Vol.10 (6), p.525-534

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets

Clinical pharmacokinetics of topotecan

Oral topotecan: bioavailability and effect of food co-administration

Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks

Phase I and Pharmacologic Study of the Combination of Paclitaxel, Cisplatin, and Topotecan Administered Intravenously Every 21 Days as First-Line Therapy in Patients With Advanced Ovarian Cancer

Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam

Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan

Distribution of ifosfamide and metabolites between plasma and erythrocytes

High-performance liquid chromatographic analysis of the investigational anticancer drug 9-aminocamptothecin, as the lactone form and as the total of the lactone and the hydroxycarboxylate forms, in micro-volumes of human plasma

Phase I and Pharmacokinetic Study of a Daily Times 5 Short Intravenous Infusion Schedule of 9-Aminocamptothecin in a Colloidal Dispersion Formulation in Patients With Advanced Solid Tumors

Sensitive Determination of the Carboxylate and Lactone Forms of the Novel Antitumor Drug Irinotecan and Its Active Metabolite in Plasma by HPLC

Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer

Phase I and pharmacokInetic (PK) study of Irinotecan (CPT11) with a prolonged (14D) infusion schedule

Oral topotecan: bioavailablity and effect of food co-administration

Oral Bioavailability of Low Dose (20mg) ‘Home-Made’ Etoposide Capsules

Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors

Deficits in facial emotion recognition indicate behavioral changes and impaired self-awareness after moderate to severe traumatic brain injury

Ant-induced soil modification and its effect on plant below-ground biomass

Modal transmission-line modeling of propagation of plane radiowaves through multilayer periodic building structures

Variation in plant performance in a grassland: Species-specific and neighbouring root mass effects

Vegetation changes following sheep grazing in abandoned mountain meadows

Year-to-Year Variation in Plant Competition in a Mountain Grassland

Interspecific competition changes reproductive output but does not increase reproductive costs in a grassland perennial

Suchergebnisse filtern